Humoral and cellular correlates of a novel immune-related adverse event and its treatment

Immune-related adverse events (irAE) may affect almost any organ system and occur at any point during treatment with immune checkpoint inhibitors (ICI). We present a patient with advanced lung cancer receiving antiprogrammed death 1 checkpoint inhibitor who developed a delayed-onset visual irAE trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonugunta, Amrit S, von Itzstein, Mitchell S, Mu-Mosley, Hong, Fattah, Farjana, Farrar, J David, Mobely, Angela, Rashdan, Sawsan, Lai, Sunny, Bhai, Salman F, Bermas, Bonnie L, Karp, David, Li, Quan-Zhen, Wakeland, Edward K, Gerber, David E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655605/
https://www.ncbi.nlm.nih.gov/pubmed/34880115
http://dx.doi.org/10.1136/jitc-2021-003585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655605/
https://www.ncbi.nlm.nih.gov/pubmed/34880115
http://dx.doi.org/10.1136/jitc-2021-003585

Ejemplares similares